SP, H., L, A., K, V., C, M., LE, M., V, A., . . . A, H. (2024). Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil Count. JAMA network open, 7(9), e2432475. https://doi.org/10.1001/jamanetworkopen.2024.32475
Chicago Style (17th ed.) CitationSP, Hibbs, et al. "Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil Count." JAMA Network Open 7, no. 9 (2024): e2432475. https://doi.org/10.1001/jamanetworkopen.2024.32475.
MLA (9th ed.) CitationSP, Hibbs, et al. "Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil Count." JAMA Network Open, vol. 7, no. 9, 2024, p. e2432475, https://doi.org/10.1001/jamanetworkopen.2024.32475.